PRevention of Macular EDema After Cataract Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

1,127

Participants

Timeline

Start Date

July 10, 2013

Primary Completion Date

November 4, 2016

Study Completion Date

November 4, 2016

Conditions
Cystoid Macular EdemaCataractDiabetes Mellitus
Interventions
DRUG

Bromfenac

DRUG

Dexamethasone

DRUG

Bevacizumab

DRUG

Triamcinolone Acetonide

Trial Locations (16)

60590

Goethe University, Frankfurt am Main

A-1140

Vienna Institute for Research in Ocular Surgery, Hanusch Krankenhaus, Vienna

Unknown

Hospital of the Brothers of Saint John of God, Vienna

Academic Medical Center, Amsterdam

Amphia Hospital Breda, Breda

Eye Hospital Zonnestraal, Hilversum

Medical Centre Haaglanden, The Hague

St. Elisabeth Hospital, Tilburg

Máxima Medical Center Veldhoven, Veldhoven

B-2650

University Hospital Antwerp, Edegem

H-1085

Semmelweis University, Budapest

1081 HZ

VU University Medical Center, Amsterdam

6419 PC

Zuyderland Medical Center, Heerlen

6202 AZ

University Eye Clinic Maastricht UMC+, Maastricht

3000-075

University Hospital Coimbra, Coimbra

08035

Instituto Microcirurgia Ocular, Barcelona

All Listed Sponsors
collaborator

European Society of Cataract and Refractive Surgeons

OTHER

lead

Maastricht University Medical Center

OTHER

NCT01774474 - PRevention of Macular EDema After Cataract Surgery | Biotech Hunter | Biotech Hunter